pralatrexate 40 MG per 2 ML Injection
- RxCUI
- 1796424
- RxNorm name
- pralatrexate 40 MG per 2 ML Injection
- Display name
- pralatrexate 40 MG per 2 ML Injection
- Full name
- pralatrexate 40 MG per 2 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:10
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pralatrexate | PRALATREXATE | Dr.Reddy's Laboratories Inc., | cc3df863-c51c-49c5-283a-d6808fb49258 | 2025-08-31 | Warnings, Adverse reactions | 1796424 |
| Folotyn | PRALATREXATE | Acrotech Biopharma Inc | 9f3d9c4d-9386-4451-b712-0fbdc5478d8f | 2024-09-26 | Warnings, Adverse reactions | 1796424 |
| Pralatrexate | PRALATREXATE | Fresenius Kabi USA, LLC | a5daa583-4965-4564-ad87-41ffe6c08a11 | 2022-11-15 | Warnings, Adverse reactions | 1796424 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9f3d9c4d-9386-4451-b712-0fbdc5478d8f | pralatrexate 40 MG per 2 ML Injection | SY | 9 | These highlights do not include all the information needed to use FOLOTYN ® safely and effectively. See full prescribing information for FOLOTYN. FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009 | 20240926 |
| 9f3d9c4d-9386-4451-b712-0fbdc5478d8f | 2 ML pralatrexate 20 MG/ML Injection | SCD | 9 | These highlights do not include all the information needed to use FOLOTYN ® safely and effectively. See full prescribing information for FOLOTYN. FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009 | 20240926 |
| 9f3d9c4d-9386-4451-b712-0fbdc5478d8f | PRALAtrexate 40 MG in 2 ML Injection | PSN | 9 | These highlights do not include all the information needed to use FOLOTYN ® safely and effectively. See full prescribing information for FOLOTYN. FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009 | 20240926 |
| cc3df863-c51c-49c5-283a-d6808fb49258 | pralatrexate 40 MG per 2 ML Injection | SY | 6 | These highlights do not include all the information needed to use PRALATREXATE INJECTION safely and effectively. See full prescribing information for PRALATREXATE INJECTION. PRALATREXATE injection, for intravenous use Initial U.S. Approval: 2009 | 20250831 |
| cc3df863-c51c-49c5-283a-d6808fb49258 | 2 ML pralatrexate 20 MG/ML Injection | SCD | 6 | These highlights do not include all the information needed to use PRALATREXATE INJECTION safely and effectively. See full prescribing information for PRALATREXATE INJECTION. PRALATREXATE injection, for intravenous use Initial U.S. Approval: 2009 | 20250831 |
| cc3df863-c51c-49c5-283a-d6808fb49258 | PRALAtrexate 40 MG in 2 ML Injection | PSN | 6 | These highlights do not include all the information needed to use PRALATREXATE INJECTION safely and effectively. See full prescribing information for PRALATREXATE INJECTION. PRALATREXATE injection, for intravenous use Initial U.S. Approval: 2009 | 20250831 |
| a5daa583-4965-4564-ad87-41ffe6c08a11 | PRALAtrexate 40 MG in 2 ML Injection | PSN | 1 | These highlights do not include all the information needed to use PRALATREXATE INJECTION safely and effectively. See full prescribing information for PRALATREXATE INJECTION. PRALATREXATE injection, for intravenous use Initial U.S. Approval: 2009 | 20221115 |
| a5daa583-4965-4564-ad87-41ffe6c08a11 | 2 ML pralatrexate 20 MG/ML Injection | SCD | 1 | These highlights do not include all the information needed to use PRALATREXATE INJECTION safely and effectively. See full prescribing information for PRALATREXATE INJECTION. PRALATREXATE injection, for intravenous use Initial U.S. Approval: 2009 | 20221115 |
| a5daa583-4965-4564-ad87-41ffe6c08a11 | pralatrexate 40 MG per 2 ML Injection | SY | 1 | These highlights do not include all the information needed to use PRALATREXATE INJECTION safely and effectively. See full prescribing information for PRALATREXATE INJECTION. PRALATREXATE injection, for intravenous use Initial U.S. Approval: 2009 | 20221115 |